VERISANTE TECHNOLOGY INC (VER-H.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:VER-H • CA92346G2036

0.02 CAD
0 (0%)
Last: Jan 30, 2026, 07:00 PM
Fundamental Rating

0

Taking everything into account, VER-H scores 0 out of 10 in our fundamental rating. VER-H was compared to 15 industry peers in the Health Care Equipment & Supplies industry. VER-H has a bad profitability rating. Also its financial health evaluation is rather negative. VER-H is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VER-H has reported negative net income.
  • In the past 5 years VER-H reported 4 times negative net income.
  • In the past 5 years VER-H always reported negative operating cash flow.
VER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFVER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

  • With a Return On Assets value of -2017.86%, VER-H is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2017.86%
ROE N/A
ROIC N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VER-H.CA Yearly ROA, ROE, ROICVER-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VER-H so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VER-H.CA Yearly Profit, Operating, Gross MarginsVER-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

0

2. Health

2.1 Basic Checks

  • VER-H has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VER-H has more shares outstanding
  • VER-H has a worse debt/assets ratio than last year.
VER-H.CA Yearly Shares OutstandingVER-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VER-H.CA Yearly Total Debt VS Total AssetsVER-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

  • Based on the Altman-Z score of -6128.08, we must say that VER-H is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6128.08, VER-H is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6128.08
ROIC/WACCN/A
WACCN/A
VER-H.CA Yearly LT Debt VS Equity VS FCFVER-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M -2M

2.3 Liquidity

  • VER-H has a Current Ratio of 0.18. This is a bad value and indicates that VER-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.18, VER-H is doing worse than 68.75% of the companies in the same industry.
  • VER-H has a Quick Ratio of 0.18. This is a bad value and indicates that VER-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.18, VER-H perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
VER-H.CA Yearly Current Assets VS Current LiabilitesVER-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.13% over the past year.
EPS 1Y (TTM)16.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VER-H.CA Yearly Revenue VS EstimatesVER-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 20K 40K 60K 80K 100K

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VER-H.CA Price Earnings VS Forward Price EarningsVER-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VER-H.CA Per share dataVER-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • VER-H does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VERISANTE TECHNOLOGY INC

TSX-V:VER-H (1/30/2026, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.06%
Ins Owner ChangeN/A
Market Cap878.80K
Revenue(TTM)N/A
Net Income(TTM)-113.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2017.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z -6128.08
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.71%
OCF growth 3YN/A
OCF growth 5YN/A

VERISANTE TECHNOLOGY INC / VER-H.CA FAQ

What is the ChartMill fundamental rating of VERISANTE TECHNOLOGY INC (VER-H.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to VER-H.CA.


Can you provide the valuation status for VERISANTE TECHNOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to VERISANTE TECHNOLOGY INC (VER-H.CA). This can be considered as Overvalued.


How profitable is VERISANTE TECHNOLOGY INC (VER-H.CA) stock?

VERISANTE TECHNOLOGY INC (VER-H.CA) has a profitability rating of 0 / 10.


How financially healthy is VERISANTE TECHNOLOGY INC?

The financial health rating of VERISANTE TECHNOLOGY INC (VER-H.CA) is 0 / 10.